Delving into the Latest Updates on Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed(Changchun BCHT Biotechnology Co.) with Synapse

Overview

Basic Info

Drug Type

Combination vaccine, Prophylactic vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesRespiratory DiseasesOther Diseases

Active Indication

DiphtheriaTetanusWhooping Cough

Inactive Indication-

Originator Organization

Changchun BCHT Biotechnology Co.

Active Organization

Changchun BCHT Biotechnology Co.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

A single-center and single-arm design was used to evaluate the safety and preliminary immunogenicity of the adsorbed cell-free leukiche (three-component) combination vaccine.Main purpose: To evaluate the safety of the adsorbed cell-free whitening break (three components) combination vaccine;Secondary purpose: To preliminarily evaluate the immunogenicity of the adsorbed cell-free whitening break (three components) combination vaccine.

Start Date10 Dec 2021

Sponsor / Collaborator

Changchun BCHT Biotechnology Co.

CTR20213181

/ Active, not recruitingPhase 1

评价吸附无细胞百白破（三组分）联合疫苗应用于儿童及婴幼儿的安全性和初步免疫原性的Ⅰ期临床研究

[Translation] Phase I clinical study to evaluate the safety and preliminary immunogenicity of adsorbed acellular diphtheria, tetanus and pertussis (three-component) combined vaccine in children and infants

主要目的：评价吸附无细胞百白破（三组分）联合疫苗的安全性次要目的：初步评价吸附无细胞百白破（三组分）联合疫苗的免疫原性

[Translation]

Primary purpose: To evaluate the safety of adsorbed acellular diphtheria, tetanus and pertussis (three-component) combined vaccine Secondary purpose: To preliminarily evaluate the immunogenicity of adsorbed acellular diphtheria, tetanus and pertussis (three-component) combined vaccine

Start Date10 Dec 2021

Sponsor / Collaborator

Changchun BCHT Biotechnology Co.

100 Clinical Results associated with Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed(Changchun BCHT Biotechnology Co.)

Login to view more data

100 Translational Medicine associated with Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed(Changchun BCHT Biotechnology Co.)

Login to view more data

100 Patents (Medical) associated with Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed(Changchun BCHT Biotechnology Co.)

Login to view more data

100 Deals associated with Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed(Changchun BCHT Biotechnology Co.)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Diphtheria	Phase 3	China	Changchun BCHT Biotechnology Co.	05 Jun 2025
Tetanus	Phase 3	China	Changchun BCHT Biotechnology Co.	05 Jun 2025
Whooping Cough	Phase 3	China	Changchun BCHT Biotechnology Co.	05 Jun 2025